Jun 1, 2019 · Percutaneous injection of radiopaque gelified ethanol for the treatment of lumbar and cervical intervertebral disk herniations: experience and clinical outcome in 80 patients.

Minimally invasive DiscoGel therapy involves the percutaneous injection of an ethanol gel into the degenerated disk’s nucleus pulposus. This paper compares the 1-year outcome of such treatment in DP and RLP patients.

Mar 1, 2015 · Recently, a substance based on radiopaque gelified ethanol has been introduced. The purpose of this study was to describe the indications, procedure, safety, and efficacy of radiopaque gelified ethanol in the percutaneous treatment of cervical and lumbar disk herniations.

Recently, percutaneous intradiscal injection of radiopaque gelified ethanol (RGE) DiscoGel ® has emerged as an effective therapeutic option in patients with LDH. Nevertheless, only few studies addressed the reliability of this technique.

Results from the current study report that intradiscal injection of a gelified ethanol and tubular discectomy were equally effective on terms of efficacy and safety for the treatment of symptomatic lumbar intervertebral disc herniation regarding the 12-month mean leg pain improvement.

The radioplaque gelified ethanol (RGE) (DiscoGel ®, Hérouville-Saint-Clair, France), is an addition to the armamentarium of potential treatments. This study aimed to evaluate the long-term efficacy of this device in treating lumbar disc herniation through a 10-year follow-up period.

Jun 12, 2018 · An emerging minimally invasive procedure is the use of DiscoGel®, a radiopaque gelified ethanol, for symptomatic DH [19, 20]. Previously published papers have demonstrated the necrotizing effect on biological tissues of the ethanol that has long been used in interventional procedures [21–23].

Jun 1, 2019 · Percutaneous image-guided intradiscal injection of gelified ethanol was introduced to treat herniated disc disease lately. The aim of the study was to assess clinical efficacy and durability over...

Objective: To evaluate the efficacy and safety of gelified ethanol, a newly developed sclerosing agent for slow-flow vascular malformations. Methods: Seventy-nine sclerotherapy procedures were performed on 44 patients with 37 venous malformations, 2 glomuvenous malformations, 2 lymphatic malformations, 2 lymphatico-venous malformations, and 1 ...

Purpose: To investigate the efficacy and safety of radiopaque gelified ethanol (RGE) injection in patients with medium to large size intervertebral lumbar disc hernias including cases requiring alternative access routes.